RECENT NEWS

The latest range of Purite ECO water purification units, available from SUEZ Water Purification Systems, is designed to minimise the volume of water and energy used by laboratories, and can reduce operating costs by over £100 per month.

Researchers are turning to INTEGRA Biosciences’ VIAFLO 96/384 handheld electronic pipette for rapid and precise filling of specialised 3D cell culture plates, to increase throughput and meet the demands of high-volume drug discovery programmes.

With the new format, analytica virtual, the world’s leading trade fair for laboratory technology, analysis and biotechnology also enables those exhibitors and visitors to participate who, due to travel restrictions, cannot come to Munich.

Summer of ’69 saw the first moon landing and John Stevens started work in pathology at Southampton. Ultimately, John would become an IBMS president and is currently Chair of the Academy for Healthcare Science.

Menarini has expanded its Surgical Specimen Management portfolio with UltraSAFE, the safe formalin dispensing solution. UltraSAFE provides total safety, standardisation and traceability without the need to change the user’s current process.

Thermo Fisher Scientific has expanded deployment model options for SampleManager LIMS software, offering laboratories end-to-end support of the software deployment in the Amazon Web Services (AWS) Cloud.

The UK government recently endorsed the reopening of conferences and exhibitions, releasing a series of guidelines to keep participants safe. To guarantee that these are followed, Easyfairs, the organiser of Lab Innovations, has partnered with SGS.

Clever Culture Systems has announced the first APAS Independence placement into a UK laboratory, at the Health Services Laboratory (HSL), a state-of-the-art facility located within the Halo building, part of London’s life sciences hub, MedCity.

Researchers in the Hadad Research Group, based in the Department of Chemistry and Biochemistry, Ohio State University, are studying organophosphate pesticides in vitro, and are using INTEGRA’s ASSIST PLUS pipetting robot to streamline workflows.

Point-of-care (POC) testing with screen-printed electrodes (SPEs) allows rapid testing of populations for viral outbreaks at affordable costs, without the need for trained specialists and/or complicated equipment.

Dr Elizabeth Lee-Lewandrowski will discuss the findings of a seven-year study on Lyme disease testing in a webinar on Thursday 30 July 2020. This is part of an ongoing series hosted by Quidel, the California-based diagnostic healthcare manufacturer.

Ultivue has announced a collaborative partnership with OracleBio to help further insights and advance personalised tumour characterisation in translational and clinical oncology research using multiplex immunofluorescence staining and imaging.

Following the recent government announcement permitting exhibitions to run in England from 1 October 2020, organisers of the Lab Innovations event have confirmed that it will run on 4–5 November at the NEC.

Pathology in Practice continues to reflect on SARS-CoV-2 infection and on COVID-19 disease, although understandably the focus may change slightly from issue to issue.

Following the success of article series on measurement uncertainty and internal quality control, Stephen MacDonald is now turning his attention to method comparison, starting in the August issue of Pathology in Practice.

HORIBA UK, Medical has launched an affordable digital tool for online skill evaluation and training in cytology. The Quality Slide Program (QSP) 2.0 draws on the wealth of haematology expertise held within HORIBA Medical globally.

Stago UK is offering UK laboratories a free trial of its widely respected Diagnostic Challenge, part of the company’s international external quality assurance (EQA) programme, My Qualiris QC.

The BioChem-VacuuCenter (BVC) fluid aspiration systems are the perfect solution for safe, sensitive and efficient aspiration of cell culture supernatants.

Freeline, a clinical stage adeno-associated virus (AAV)-based gene therapy company, has announced new data on its AAV gene therapy product candidate, FLT180a, in severe haemophilia B patients.

Researchers are designing microorganisms to help break down pollutants and toxins like aflatoxins that contaminate food crops and pose a serious health threat to humans and livestock.